Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Annals of Clinical Biochemistry|November 12, 2015
Therapeutic drug monitoring of antimicrobialsIndran Balakrishnan, Robert J Shorten
Infectious Disease Reports|January 29, 2014
Successful treatment of Leuconostoc bacteremia in a neutropenic patient with tigecyclineTrupti Patel, Aoife Molloy, Robin Smith, et al.
Clinical and Molecular Allergy : CMA|November 29, 2013
β-lactam allergy: clinical implications and costsGiovanni Satta, Victoria Hill, Marisa Lanzman, et al.
Journal of Microbiological Methods|January 31, 2015
A method for the detection of antibiotic resistance markers in clinical strains of Escherichia coli using MALDI mass spectrometryPhilippa J Hart, Emmanuel Wey, Timothy D McHugh, et al.
Microbiology Spectrum|January 30, 2023
Pharmacokinetic/Pharmacodynamic Determination of Systemic MIC Breakpoints for Intermittent, Extended, and Continuous Infusion Dosage Regimens of MecillinamVasiliki Koumaki, Aristides Dokoumetzidis, Maria Galini Faidra Angelerou, et al.
Scientific Reports|November 25, 2025
Pharmacodynamic interactions among meropenem ciprofloxacin and gentamicin in an in-vitro modelZahra Sadouki, Emmanuel Q Wey, Liam Read, et al.
Tropical Medicine & International Health : TM & IH|March 5, 2011
Short Communication: Low seroprevalence of cryptococcal antigenaemia in patients with advanced HIV infection enrolling in an antiretroviral programme in GhanaYaasir Mamoojee, Shaid Shakoor, Rebecca L Gorton, et al.
The Journal of Antimicrobial Chemotherapy|January 19, 2021
Exclusion of bacterial co-infection in COVID-19 using baseline inflammatory markers and their response to antibioticsClaire Y Mason, Tanmay Kanitkar, Charlotte J Richardson, et al.
International Journal of Antimicrobial Agents|November 14, 2009
Antimicrobial treatment and clinical outcome for infections with carbapenem- and multiply-resistant Acinetobacter baumannii around LondonDavid M Livermore, Robert L R Hill, Hazel Thomson, et al.
The Journal of Antimicrobial Chemotherapy|August 4, 2011
Temocillin use in England: clinical and microbiological efficacies in infections caused by extended-spectrum and/or derepressed AmpC β-lactamase-producing EnterobacteriaceaeIndran Balakrishnan, F Mustafa Awad-El-Kariem, Adnan Aali, et al.
Pageof 2